If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Mucocutaneous Lymph Node Syndrome Medicine & Life Sciences
Calcitonin Medicine & Life Sciences
Blood Coagulation Factor Inhibitors Medicine & Life Sciences
Central Nervous System Bacterial Infections Medicine & Life Sciences
Coronary Aneurysm Medicine & Life Sciences
Intravenous Immunoglobulins Medicine & Life Sciences
Drug Hypersensitivity Syndrome Medicine & Life Sciences
Protein S Deficiency Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

  • 63 Citations
  • 5 h-Index
  • 16 Article
  • 1 Letter

Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease

Nakashima, Y., Nanishi, E., Yamamura, K., Uike, K., Terashi, E., Hirata, Y., Nagata, H., Morihana, E., Tanaka, T., Honjo, S., Takada, H. & Ohga, S., Feb 1 2019, In : Cytokine. 114, p. 26-31 6 p.

Research output: Contribution to journalArticle

Mucocutaneous Lymph Node Syndrome
Calcitonin
Immunoglobulins
Intravenous Immunoglobulins
Serum
1 Citation (Scopus)

Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease

Nagatomo, Y., Muneuchi, J., Nakashima, Y., Nanishi, E., Shirozu, H., Watanabe, M., Uike, K., Nagata, H., Hirata, Y., Yamamura, K., Takahashi, Y., Okada, S., Suzuki, Y., Hasegawa, S. & Ohga, S., Nov 15 2018, In : International Journal of Cardiology. 271, p. 317-321 5 p.

Research output: Contribution to journalArticle

Coronary Aneurysm
Mucocutaneous Lymph Node Syndrome
Coronary Vessels
Therapeutics
Infliximab

Clarithromycin plus intravenous immunoglobulin therapy can reduce the relapse rate of Kawasaki disease: A phase 2, open-label, randomized control study

Nanishi, E., Nishio, H., Takada, H., Yamamura, K., Fukazawa, M., Furuno, K., Mizuno, Y., Saigo, K., Kadoya, R., Ohbuchi, N., Onoe, Y., Yamashita, H., Nakayama, H., Hara, T., Ohno, T., Takahashi, Y., Hatae, K., Harada, T., Shimose, T., Kishimoto, J. & 2 othersOhga, S. & Hara, T., Jul 1 2017, In : Journal of the American Heart Association. 6, 7, e005370.

Research output: Contribution to journalArticle

Mucocutaneous Lymph Node Syndrome
Passive Immunization
Clarithromycin
Intravenous Immunoglobulins
Recurrence

Intramuscular Venous Malformation in an Infant Masquerading as Recurrent Gonarthritis

Nanishi, E., Hoshina, T., Nishio, H., aman, M., Sakamoto, A., Ohga, S. & Hara, T., Apr 1 2017, In : Pediatrics and Neonatology. 58, 2, p. 185-186 2 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Activation of Nod1 signaling induces fetal growth restriction and death through fetal and maternal vasculopathy

Inoue, H., Nishio, H., Takada, H., Sakai, Y., Nanishi, E., Ochiai, M., Onimaru, M., Chen, S. J., Matsui, T. & Hara, T., Mar 15 2016, In : Journal of Immunology. 196, 6, p. 2779-2787 9 p.

Research output: Contribution to journalArticle

Fetal Death
Fetal Development
Nucleotides
Mothers
Fetus